Article Abstract
Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder. [CME]
Joseph Biederman, M.D., opened the symposium by reviewing the history of attention-deficit/hyperactivity disorder (ADHD), neurologic impairment in individuals with ADHD, and the prevalence of the disorder and comorbid conditions. Dr. Biederman also explained how, together, symptoms and comorbid conditions result in the impairments associated with ADHD.
From the Editors
New Series
The JCP Podcast
Insightful, evidence-based conversations on the latest in psychiatric care — from the editors of JCP.
Download Premium PDF
Enjoy this premium PDF as part of your membership benefits!
